IL-9: Function, sources, and detection

Methods in Molecular Biology

Volumn 1585, Issue , 2017, Pages 21-35

  Rojas Zuleta, Wilmer Gerardo ^a   Sanchez, Elizabeth ^b  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Interleukin 9; Mast cell growth enhancing activity; P 40; T Lymphocyte growth factor; Th9 cells

Indexed keywords

CYTOKINE; INTERLEUKIN 9;

ASTHMA; HUMAN; HYPERSENSITIVITY; METABOLISM; REGULATORY T LYMPHOCYTE; TH17 CELL; TH2 CELL;

ASTHMA; CYTOKINES; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-9; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TH2 CELLS;

EID: 85019164335     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-6877-0_2     Document Type: Chapter

References (65)

1. Noelle RJ, Nowak EC (2010) Cellular sources and immune functions of interleukin-9. Nat Rev Immunol 10(10):683-687. doi:10.1038/nri2848
2. Renauld JC, Goethals A, Houssiau F, Van Roost E, Van Snick J (1990) Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40. Cytokine 2(1):9-12
3. Nicolaides NC, Holroyd KJ, Ewart SL, Eleff SM, Kiser MB, Dragwa CR, Sullivan CD, Grasso L, Zhang LY, Messler CJ, Zhou T, Kleeberger SR, Buetow KH, Levitt RC (1997) Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci U S A 94(24):13175-13180
4. Mock BA, Krall M, Kozak CA, Nesbitt MN, McBride OW, Renauld JC, Van Snick J (1990) IL9 maps to mouse chromosome 13 and human chromosome 5. Immunogenetics 31(4):265-270
5. Kaplan MH (2013) Th9 cells: differentiation and disease. Immunol Rev 252(1):104-115. doi:10.1111/imr.12028
6. Perumal NB, Kaplan MH (2011) Regulating IL-9 transcription in T helper cells. Trends Immunol 32(4):146-150. doi:10.1016/j.it.2011.01.006
7. Demoulin JB, Renauld JC (1998) Signalling by cytokines interacting with the interleukin-2 receptor gamma chain. Cytokines Cell Mol Ther 4(4):243-256
8. Knoops L, Renauld JC (2004) IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors 22(4):207-215. doi:10.1080/08977190410001720879
9. Van Snick J, Goethals A, Renauld JC, Van Roost E, Uyttenhove C, Rubira MR, Moritz RL, Simpson RJ (1989) Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J Exp Med 169(1):363-368
10. Uyttenhove C, Simpson RJ, Van Snick J (1988) Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci U S A 85(18):6934-6938
11. Schmitt E, Van Brandwijk R, Van Snick J, Siebold B, Rude E (1989) TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor. Eur J Immunol 19(11):2167-2170. doi:10.1002/eji.1830191130
12. Stassen M, Schmitt E, Bopp T (2012) From interleukin-9 to T helper 9 cells. Ann N Y Acad Sci 1247:56-68. doi:10.1111/j.1749-6632.2011.06351.x
13. Schmitt E, Germann T, Goedert S, Hoehn P, Huels C, Koelsch S, Kuhn R, Muller W, Palm N, Rude E (1994) IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol 153(9):3989-3996
14. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C, Stockinger B (2008) Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9(12):1341-1346. doi:10.1038/ni.1659
15. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, Khoury S, Oukka M, Kuchroo VK (2008) IL-4 inhibits TGF-beta-­ induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol (12):1347-1355. doi:10.1038/ni.1677
16. Beriou G, Bradshaw EM, Lozano E, Costantino CM, Hastings WD, Orban T, Elyaman W, Khoury SJ, Kuchroo VK, Baecher-Allan C, Hafler DA (2010) TGF-beta induces IL-9 production from human Th17 cells. J Immunol 185(1):46-54. doi:10.4049/jimmunol.1000356
17. Stassen M, Arnold M, Hultner L, Muller C, Neudorfl C, Reineke T, Schmitt E (2000) Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J Immunol 164(11):5549-5555
18. Lauwerys BR, Garot N, Renauld JC, Houssiau FA (2000) Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J Immunol 165(4):1847-1853
19. Nagato T, Kobayashi H, Kishibe K, Takahara M, Ogino T, Ishii H, Oikawa K, Aoki N, Sato K, Kimura S, Shimizu N, Tateno M, Harabuchi Y (2005) Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients. Clin Cancer Res 11(23):8250-8257. doi:10.1158/1078-0432.ccr-05-1426
20. Houssiau FA, Renauld JC, Stevens M, Lehmann F, Lethe B, Coulie PG, Van Snick J (1993) Human T cell lines and clones respond to IL-9. J Immunol 150(7):2634-2640
21. Hultner L, Druez C, Moeller J, Uyttenhove C, Schmitt E, Rude E, Dormer P, Van Snick J (1990) Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol 20(6):1413-1416. doi:10.1002/eji.1830200632
22. Yang YC, Ricciardi S, Ciarletta A, Calvetti J, Kelleher K, Clark SC (1989) Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40. Blood 74(6):1880-1884
23. Temann UA, Laouar Y, Eynon EE, Homer R, Flavell RA (2007) IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int Immunol 19(1):1-10. doi:10.1093/intimm/dxl117
24. Zhao P, Xiao X, Ghobrial RM, Li XC (2013) IL-9 and Th9 cells: progress and challenges. Int Immunol 25(10):547-551. doi:10.1093/intimm/dxt039
25. Jones CP, Gregory LG, Causton B, Campbell GA, Lloyd CM (2012) Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol 129(4):1000-1010.e1003. doi:10.1016/j.jaci.2011.12.965
26. Xing J, Wu Y, Ni B (2011) Th9: a new player in asthma pathogenesis? J Asthma 48(2):115-125. doi:10.3109/02770903.2011.554944
27. Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N, Gerlitzki B, Hoffmann M, Ulges A, Taube C, Dehzad N, Becker M, Stassen M, Steinborn A, Lohoff M, Schild H, Schmitt E, Bopp T (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33(2):192-202. doi:10.1016/j.immuni.2010.07.014
28. Purwar R, Schlapbach C, Xiao S, Kang HS, Elyaman W, Jiang X, Jetten AM, Khoury SJ, Fuhlbrigge RC, Kuchroo VK, Clark RA, Kupper TS (2012) Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 18(8):1248-1253. doi:10.1038/nm.2856
29. Faulkner H, Humphreys N, Renauld JC, Van Snick J, Grencis R (1997) Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur J Immunol 27(10):2536-2540. doi:10.1002/eji.1830271011
30. Townsend JM, Fallon GP, Matthews JD, Smith P, Jolin EH, McKenzie NA (2000) IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13(4):573-583
31. Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, Scott ZA, Coyle AJ, Reed JL, Van Snick J, Strom TB, Zheng XX, Noelle RJ (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442(7106):997-1002. doi:10.1038/nature05010
32. Yao W, Tepper RS, Kaplan MH (2011) Predisposition to the development of IL-9-secreting T cells in atopic infants. J Allergy Clin Immunol 128(6):1357-1360.e1355. doi:10.1016/j.jaci.2011.06.019
33. Ouyang H, Shi Y, Liu Z, Feng S, Li L, Su N, Lu Y, Kong S (2013) Increased interleukin9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus. Mol Med Rep 7(3):1031-1037. doi:10.3892/mmr.2013.1258
34. Dantas AT, Marques CD, da Rocha Junior LF, Cavalcanti MB, Goncalves SM, Cardoso PR, Mariz Hde A, Rego MJ, Duarte AL, Pitta Ida R, Pitta MG (2015) Increased serum interleukin-9 levels in rheumatoid arthritis and systemic lupus erythematosus: pathogenic role or just an epiphenomenon? Dis Markers 2015:519638. doi:10.1155/2015/519638
35. Ciccia F, Guggino G, Rizzo A, Manzo A, Vitolo B, La Manna MP, Giardina G, Sireci G, Dieli F, Montecucco CM, Alessandro R, Triolo G (2015) Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford, UK). doi:10.1093/rheumatology/kev252
36. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S (2011) Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis. J Rheumatol 38(10):2193-2197. doi:10.3899/jrheum.110268
37. Pan HF, Leng RX, Li XP, Zheng SG, Ye DQ (2013) Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases. Cytokine Growth Factor Rev 24(6):515-522
38. Rojas-Zuleta WG, Vásquez G (2016) Th9 lymphocytes: a recent history from IL-9 to its potential role in rheumatic diseases. Autoimmun Rev 15(7):649-655. doi:10.1016/j.autrev.2016.02.020
39. Gessner A, Blum H, Rollinghoff M (1993) Differential regulation of IL-9-expression after infection with leishmania major in susceptible and resistant mice. Immunobiology 189(5):419-435. doi:10.1016/s0171-2985(11)80414-6
40. Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, Jabeen R, McKinley C, Ahyi AN, Han L, Nguyen ET, Robertson MJ, Perumal NB, Tepper RS, Nutt SL, Kaplan MH (2010) The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 11(6):527-534. doi:10.1038/ni.1867
41. Monteiro M, Agua-Doce A, Almeida CF, Fonseca-Pereira D, Veiga-Fernandes H, Graca L (2015) IL-9 expression by invariant NKT cells is not imprinted during thymic development. J Immunol 195(7):3463-3471. doi:10.4049/jimmunol.1403170
42. Jones TG, Hallgren J, Humbles A, Burwell T, Finkelman FD, Alcaide P, Austen KF, Gurish MF (2009) Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J Immunol 183(8):5251-5260. doi:10.4049/jimmunol.0901471
43. Wiener Z, Falus A, Toth S (2004) IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice. Cytokine 26(3):122-130. doi:10.1016/j.cyto.2004.01.006
44. Stassen M, Klein M, Becker M, Bopp T, Neudorfl C, Richter C, Heib V, Klein-Hessling S, Serfling E, Schild H, Schmitt E (2007) p38 MAP kinase drives the expression of mast cell-derived IL-9 via activation of the transcription factor GATA-1. Mol Immunol 44(5):926-933. doi:10.1016/j.molimm.2006.03.019
45. Chen C-Y, Lee J-B, Liu B, Ohta S, Wang P-Y, Kartashov Andrey V, Mugge L, Abonia JP, Barski A, Izuhara K, Rothenberg Marc E, Finkelman Fred D, Hogan Simon P, Wang Y-H (2015) Induction of interleukin-9-producing mucosal mast cells promotes susceptibility to IgE-mediated experimental food allergy. Immunity 43(4):788-802. doi:10.1016/j.immuni.2015.08.020
46. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100(6):655-669
47. Zheng W, Flavell RA (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89(4):587-596
48. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science (New York, NY) 299(5609):1057-1061. doi:10.1126/science.1079490
49. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126(6):1121-1133. doi:10.1016/j.cell.2006.07.035
50. Angkasekwinai P, Chang SH, Thapa M, Watarai H, Dong C (2010) Regulation of IL-9 expression by IL-25 signaling. Nat Immunol 11(3):250-256. doi:10.1038/ni.1846
51. Mikami N, Miyagi Y, Sueda K, Takatsuji M, Fukada S, Yamamoto H, Tsujikawa K (2013) Calcitonin gene-related peptide and cyclic adenosine 5’-monophosphate/protein kinase A pathway promote IL-9 production in Th9 differentiation process. J Immunol 190(8):4046-4055. doi:10.4049/jimmunol.1203102
52. Yao W, Zhang Y, Jabeen R, Nguyen ET, Wilkes DS, Tepper RS, Kaplan MH, Zhou B (2013) Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 38(2):360-372. doi:10.1016/j.immuni.2013.01.007
53. Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J, Bettelli E, Oukka M, van Snick J, Renauld JC, Kuchroo VK, Khoury SJ (2009) IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A 106(31):12885-12890. doi:10.1073/pnas.0812530106
54. Liu Y, Teige I, Birnir B, Issazadeh-Navikas S (2006) Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 12(5):518-525. doi:10.1038/nm1402
55. Roediger B, Weninger W (2015) Group 2 innate lymphoid cells in the regulation of immune responses. Adv Immunol 125:111-154. doi:10.1016/bs.ai.2014.09.004
56. Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M, Lahl K, Sparwasser T, Helmby H, Stockinger B (2011) An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 12(11):1071-1077. doi:10.1038/ni.2133
57. Wilhelm C, Turner JE, Van Snick J, Stockinger B (2012) The many lives of IL-9: a question of survival? Nat Immunol 13(7):637-641. doi:10.1038/ni.2303
58. Spits H, Di Santo JP (2011) The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 12(1):21-27. doi:10.1038/ni.1962
59. Turner JE, Morrison PJ, Wilhelm C, Wilson M, Ahlfors H, Renauld JC, Panzer U, Helmby H, Stockinger B (2013) IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med 210(13):2951-2965. doi:10.1084/jem.20130071
60. Stordeur P, Poulin LF, Craciun L, Zhou L, Schandene L, de Lavareille A, Goriely S, Goldman M (2002) Cytokine mRNA quantification by real-time PCR. J Immunol Methods 259(1-2):55-64
61. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonak J, Lind K, Sindelka R, Sjoback R, Sjogreen B, Strombom L, Stahlberg A, Zoric N (2006) The real-time polymerase chain reaction. Mol Aspects Med 27(2-3):95-125. doi:10.1016/j.mam.2005.12.007
62. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, CA) 25(4):402-408. doi:10.1006/meth.2001.1262
63. Renauld JC, Van Snick J (2002) Measurement of mouse and human interleukin 9. Curr Protoc Immunol Chapter 6:Unit 6.13. doi:10.1002/0471142735.im0613s51
64. Shevach EM (2001) Labeling cells in microtiter plates for determination of [3H]thymidine uptake. Curr Protoc Immunol Appendix 3:Appendix 3D. doi:10.1002/0471142735.ima03ds21
65. Avanzi GC, Brizzi MF, Giannotti J, Ciarletta A, Yang YC, Pegoraro L, Clark SC (1990) M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 145(3):458-464. doi:10.1002/jcp.1041450310